95 related articles for article (PubMed ID: 496871)
21. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
22. Double-blind controlled study of the efficacy and pharmacological properties of heparan sulfate in patients with occlusive arterial disease of the lower limbs.
Strano A; Pinto A; Galati D
Drugs Exp Clin Res; 1990; 16(10):543-50. PubMed ID: 2151628
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the platelet component in chronic obliterating vascular disease of the lower limbs].
Avellone G; Nova S; Gullotti D; Mandalà V
Boll Soc Ital Cardiol; 1979; 24(2):135-41. PubMed ID: 548089
[No Abstract] [Full Text] [Related]
24. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
Juon M; Messelhäuser I
Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
[No Abstract] [Full Text] [Related]
25. Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension.
Gueguen-Duchesne M; Durand F; Le Goff MC; Genetet B
Prog Clin Biol Res; 1988; 280():401-6. PubMed ID: 3174703
[No Abstract] [Full Text] [Related]
26. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
27. [Studies in animal experiments on determination of blood and organ levels of o-(beta-hydroxyethyl)-rutosides (HR) after i.p. administration (author's transl)].
Reinartz G; Wurst F
Arzneimittelforschung; 1980; 30(4):657-9. PubMed ID: 7190409
[TBL] [Abstract][Full Text] [Related]
28. Improvement of subcutaneous nutritional blood flow in the forefoot by hydroxyethylrutosides in patients with arterial insufficiency: case studies.
Jelnes R; Gaardsting O; Holm A
Angiology; 1986 Mar; 37(3 Pt 1):198-202. PubMed ID: 3706821
[TBL] [Abstract][Full Text] [Related]
29. [Anti-edema activity of injectable Venoruton in abdominal surgery].
De Anna D; Liboni A; Paoli M; Pollinzi V; Malin L; Mannella P; Ambroso G; Oberhauser V
Minerva Chir; 1979 Oct; 34(20):1377-92. PubMed ID: 503345
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the effects on the peripheral blood circulation of i.v. administration of high doses of phosphocreatinine in patients with arterial diseases].
de Divitiis O; Abate S; Di Somma S; Ferulano GP; Petitto M; Vanni L; Villari B; Di Lillo S; Fazio S; Picilli M
Minerva Cardioangiol; 1986 Oct; 34(10):671-80. PubMed ID: 2949160
[No Abstract] [Full Text] [Related]
31. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
[No Abstract] [Full Text] [Related]
32. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
Barbarino C; Pezzangora V
Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
[No Abstract] [Full Text] [Related]
33. [Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Agolini G; Cavallini GM
Clin Ter; 1987 Jan; 120(2):101-10. PubMed ID: 2972438
[No Abstract] [Full Text] [Related]
34. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
Bagliani A; Argenteri A; La Rosa A
Clin Ter; 1982 Dec; 103(6):647-61. PubMed ID: 7160147
[No Abstract] [Full Text] [Related]
35. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
[No Abstract] [Full Text] [Related]
36. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Piller NB; Morgan RG; Casley-Smith JR
Br J Plast Surg; 1988 Jan; 41(1):20-7. PubMed ID: 3278764
[TBL] [Abstract][Full Text] [Related]
37. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
[TBL] [Abstract][Full Text] [Related]
38. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
Fagrell B; Lundberg G; Olsson A; Ostergren J
Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
[No Abstract] [Full Text] [Related]
39. [Venalot used in therapy of phlebopathies].
Lacativa AS
Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
[No Abstract] [Full Text] [Related]
40. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
Aligne C; Mosnier M; Mistretta F; Larguier JS
J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
